protein interactions in a cell. These interactions drive nearly 34 every aspect of cellular function. Small molecules offer an 35 opportunity to explore these interactions in normal and 36 pathological processes. Protein−protein interactions exhibit a 37 wide range of binding thermodynamics and kinetics from weak 38 interactions that occur over small interfaces to tight and stable 39 protein−protein interactions that occur over large interfaces 40 The binding poses of select derivatives of 1 (IPR-1110) were 248 generated using the cocrystal structure of uPAR in complex 249 with 3 (IPR-1175) as a guide in Maestro. The derivatives were 250 docked in a 21 Å box centered on the complexed ligand using 251 Glide 39 (Schrodinger, LLC) in standard precision (SP) mode. t1 252 The common core structure of the analogues found in 100 of the 1000 snapshots used in the free energy calculations.
296
The maximal number of cycles of minimization was set to 297 10000. The convergence criterion for the energy gradient to 298 stop minimization was 0.5.
299
The MM-GBSA binding free energy is expressed as 
where the first and second terms represent the average 328 contribution over snapshots i from the MD simulation in 329 residues j on the receptor and ligand, respectively. The term 330 E(i,j) corresponds to the contribution of the gas-phase and 331 solvation energies, that is
GAS GBSOLV VDW ELE GB SURF 332 where E VDW and E ELE are the van der Waals and electrostatic 333 energies in the gas phase (E GAS ), respectively. E GB and E SURF are 334 the polar and nonpolar contributions to the solvation free 335 energy by the GB solvation model (E GBSOLV ), respectively. 336 Entropy is not included in the decomposition method.
337
The GB model is described in detail by Onufriev and 338 associates 55 and in the AMBER14 manual. The GB model we 339 selected (igb = 2, GB OBC model I) approximates the solvation 340 electrostatic E GB by an analytical formula:
where r ij is the distance between atoms i and j, R i and R j are the 342 effective Born radii of atoms i and j, respectively, K is the 343 Debye−Huckel screening parameter, ε is the dielectric 344 constant, and f GB is a smooth function. Each atom in the GB 345 model is represented as a sphere with radius ρ i with charge q i . 346 The f GB function is expressed as
347 and is used to describe the distance between two atoms and 348 their effective Born radii.
349
The nonpolar contribution to the solvation free energy is 350 calculated by approximating the total SASA of the molecule: was straightforward ( Figure S1 ) as described previously. Figure S4 ) showed no inhibition of this interaction up to 25 414 μM. The effect of 1 on the CaVαβ interaction at 50 and 100 415 μM can be attributed to aggregation considering the sharp rise 416 in activity from nearly 0% inhibition at 25 μM to more than 417 75% inhibition at 50 μM. This was not observed for uPAR, 418 whereby 1 exhibited a gradual increase in its level of inhibition 419 of binding of AE-147 to uPAR ( Figure S4 ). These studies 420 confirm that the compounds bind to uPAR in a selective 421 manner as evidenced by the lack of activity against another 422 unrelated protein−protein interaction. It is possible that 423 compound 1 inhibits interactions that are similar to the 424 uPAR·uPA interaction. Future studies that explore compounds 425 in cell culture should explore these compounds for inhibition of 426 interactions that are similar to uPAR·uPA interactions.
427
Crystal Structures of Compounds Bound to uPAR. The 428 crystal structure of uPAR was previously determined in f1 429 complex with ATF (PDB entry 2FD6) (Figure 1a ) or α-helical 430 peptide AE-147 (PDB entry 1YWH) (Figure 1b) . These 431 structures revealed a large interface between uPAR and uPA 432 that contains several hot spots, including Leu-55, Tyr-57, Leu-433 66, Asp-140, and Leu-150. All the hot spots on uPAR at the 434 uPAR·uPA interaction are listed in Table S1 . We hypothesized 435 that compounds that disrupt the protein−protein interaction 436 between uPAR and uPA likely directly engage these hot spots. 437 To test this hypothesis, we resorted to X-ray crystallography to 438 determine the structure of 1 (IPR-1110) and derivatives in 439 complex with uPAR. We also attempted to determine the 440 structures of pyrazole, piperidinone, pyrrolidinone, and butan-441 amine compounds that we had previously shown to bind to 442 uPAR. 21 We obtained structures for two compounds bound to f2 443 uPAR, namely, pyrrolinone 12 (IPR-1175) ( Figure 2 and Table   f3 444 S2) and pyrazole 3 (IPR-737) ( Figure 3 and Table S3 ).
445
The structure of uPAR in complex with 12 reveals that the 446 compound is ensconced deeply in the pocket that is occupied 
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Article 481 AE-147 peptide shows that two hydrophobic residues on the 482 peptide (Phe-5 and Tyr-8) come in direct contact with Ile-66 of 483 uPAR (Figure 1b) . Hence, interaction with Ile-66 may explain 484 why 3 (IPR-737) can disrupt binding of AE-147 to uPAR. 485 Engagement of Ile-66, however, is not sufficient to disrupt the 486 full uPAR·uPA ATF interaction. Ile-66 of 3 (IPR-737) binds to 487 uPAR at a site that is occupied by Ile-28 and Trp-30 of uPA. 488 These two residues are located on the β strands of the β hairpin 489 of the GFD domain of uPA (Figure 3c ). This is in contrast to 490 12 (IPR-1175), which overlaps with amino acids located on the 491 loop region of the β hairpin (Figure 2c ).
492
Structure−Activity Relationship. We prepared 46 493 derivatives of 1 (IPR-1110) to explore the uPAR binding site 494 at the uPAR·uPA interface. Substituents at R 1 −R 3 of 1 (IPR-495 1110) were explored. The binding mode of 12 (IPR-1175) 496 (Figure 2a,b) shows that R 1 groups point toward a large 497 hydrophobic cavity occupied by several uPA hot-spot residues. 498 An aromatic group at R 1 was generally required for inhibition of 499 uPAR·uPA interaction. This is evidenced by complete loss of 500 activity of 25 (IPR-1177), which lacks an aromatic ring at R 1 . 501 
538
Despite the highly favorable cation−π interaction of the R 2 539 group with Arg-53, the substituent has significant exposure to 540 solvent. The addition of a methoxy group at the meta position 541 of the aromatic ring of R 2 (21 and 28) reduced the binding 542 affinity and weakened the potency for inhibition of uPAR·uPA 543 interaction. Replacing the fluorine on 4 (IPR-1201) with a 544 chlorine on 7 (IPR-1178), however, does not have much 545 impact on the binding affinity or inhibition of uPAR·uPA. 546 Moving the fluorine from the meta to ortho position on 10 547 reduces the K i and IC 50 by 2-fold. It is interesting to note that a 548 methoxy group at the meta position of 21 has a much more 549 significant impact on both binding with a 10-fold reduction in 550 K i and inhibition of the protein−protein interaction as 551 evidenced by a nearly 5-fold increase in IC 50 . Replacing the 552 hydrogen atom with a fluorine atom of this compound to 553 generate 28 improves the K i and IC 50 by 5-fold versus those of 554 compound 21. In compound 24, we introduced a tert-butyl 555 group at the para position of the aromatic ring at R 2 , which led 556 to complete abrogation of the inhibition of uPAR·uPA 557 interaction (IC 50 not determined), although direct binding to 558 uPAR was still detected but its level was reduced by more than 559 an order of magnitude (K i = 15.9 ± 2.8 μM). A nearly similar 560 effect was observed for 33 (IPR-1157), and an even more 
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Article 586 potential energies, the polar and nonpolar solvation energies, 587 and the entropy (Table S4 ). The calculated MM-GBSA free 588 energy correlated positively with the experimentally determined 589 K i values with a Pearson's r of 0.8, a Spearman's ρ of 0.41, and a 590 Kendall's τ of 0.29 (Figure 4a ).
591
To gain deeper insight into the interaction of the small 592 molecules with individual residues on uPAR, a decomposition 593 energy calculation was performed for each compound (Figure  594 4b ). The decomposition energy consists of polar and nonpolar 595 interaction potential energy, and the polar and nonpolar 596 solvation energies. These calculations were also performed for 597 the uPAR·uPA complex. On uPAR, mutations at 21 residues at 598 the uPAR·uPA interface significantly impaired the interaction. 18 599 Among these residues, only a subset is considered hot spots by 600 the traditional definition (ΔΔG > 1 kcal mol −1 ). Additionally, 601 not all hot spots are included in this list of residues. We 602 examine the local interaction between uPA and compounds 603 with uPAR at these residues ( Figure 4c ). As expected, uPA 604 strongly engaged these residues. The change in free energy 605 from the experimental alanine scan correlated with the per-606 residue decomposition (r = 0.38, ρ = 0.17, and τ = 0.01). When 607 only hot-spot residues are considered, the correlation decreases 608 to r = 0.18, ρ = 0.11, and τ = 0.10. At the 21 residues 609 mentioned above, the correlation is r = 0.11, ρ = 0. (Table S5 ). In addition, the experimental kinetic 623 rate constants were also compared to the residue decom-624 position energies of these derivatives (Table S6) . residues. We ran explicit-solvent molecular dynamics simu- small molecules disrupt these interactions by engaging hot Figure 5 . Cooperativity of singly and doubly mutated (a) uPAR·uPA and (b) uPAR·12 complexes. The difference and standard error between the free energy of each mutant with the respective wild-type complex (blue), the sum of the ΔΔG of the Arg-53-Ala mutant and the single mutant (red), and the double mutant (green). Statistical significance (independent two-sample t test): *p < 0.01, **p < 0.001, and ***p < 0.0001. lower-affinity compounds. Also, the lack of exposed nucleo-774 philes such as cysteine residues on uPAR makes it highly 
